FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1056-1058 October 3, 1996 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Pregnancy is frequently thought of as a time of emotional well-being for women, but it does not protect them from mood instability. In fact, it is a risk factor for depressive illness, defined as a state of psychological pain with dysregulation of mood.

It is generally agreed that drugs of any type should be taken during pregnancy only when the risks to the mother and the fetus of no treatment outweigh the risks of taking the drug. In the case of depressive illness, the risks of no treatment in a pregnant woman might be high when the woman is suicidal, . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Costa, L. G., Steardo, L., Cuomo, V. (2004). Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects. Pharmacol. Rev. 56: 103-147 [Abstract] [Full Text]  
• Schnyer, R. N., Manber, R., Fitzcharles, A. J. (2003). Acupuncture Treatment for Depression During Pregnancy: Conceptual Framework and Two Case Reports. Complementary Health Practice Review 8: 40-53 [Abstract]  
• Oren, D. A., Wisner, K. L., Spinelli, M., Epperson, C. N., Peindl, K. S., Terman, J. S., Terman, M. (2002). An Open Trial of Morning Light Therapy for Treatment of Antepartum Depression. Am. J. Psychiatry 159: 666-669 [Abstract] [Full Text]  
• Committee on Drugs, (2000). Use of Psychoactive Medication During Pregnancy and Possible Effects on the Fetus and Newborn. Pediatrics 105: 880-887 [Abstract] [Full Text]  
• Wisner, K. L., Gelenberg, A. J., Leonard, H., Zarin, D., Frank, E. (1999). Pharmacologic Treatment of Depression During Pregnancy. JAMA 282: 1264-1269 [Abstract] [Full Text]  
• Bengel, D., Murphy, D. L., Andrews, A. M., Wichems, C. H., Feltner, D., Heils, A., Mössner, R., Westphal, H., Lesch, K.-P. (1998). Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine ("Ecstasy") in Serotonin Transporter-Deficient Mice. Mol. Pharmacol. 53: 649-655 [Abstract] [Full Text]  
• Goodwin, G. M (1998). Antidepressant exposure before birth was not associated with language, physical, or behavioural development. Evid. Based Ment. Health 1: 30-30 [Full Text]  
• (1996). Birth Outcomes with Prenatal Fluoxetine. JWatch Psychiatry 1996: 10-10 [Full Text]  
• (1996). Prozac in Pregnancy. JWatch Women's Health 1996: 6-6 [Full Text]  
• (1996). BIRTH OUTCOMES WITH FLUOXETINE USE DURING PREGNANCY. JWatch General 1996: 3-3 [Full Text]